Mar 19 2007, 12:25 PM EST GEN News HighlightsBioponic Phytoceuticals reported that Curecumin™, a Bioresonant Phytotherapeutic® form of Turmeric containing curcumin, may be an important treatment for prostate cancer.
In the March 1 issue of Cancer Research, scientists from the Comprehensive Cancer Center of the University of Alabama report on a study designed to elucidate the molecular anticancer effect of curcumin in a preclinical prostate cancer model. Curcumin was found to decrease the mRNA and protein expression of the oncoprotein MDM2 and to enhance the expression of tumor modulator p21.
